Loading...
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats
Although bortezomib (BTZ) is the frontline treatment for multiple myeloma, its clinical use is limited by the occurrence of painful peripheral neuropathy, whose treatment is still an unmet clinical need. Previous studies have shown chronic BTZ administration (0.20 mg/kg intravenously three times a w...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3392714/ https://ncbi.nlm.nih.gov/pubmed/22792002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S32122 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|